Increase in the Content of Quinolinic Acid in Cerebrospinal Fluid and Frontal Cortex of Patients with Hepatic Failure

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Journal of Neurochemistry

• Publication date

  1986-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1471-4159.1986.tb13071.xPMID 2430055
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CNS tryptamine metabolism in hepatic coma

  2005cited by this paper
• Excitatory effects of kynurenine and its metabolites, amino acids and convulsants administered into brain ventricles: Differences between rats and mice

  2005cited by this paper
• Senile dementia and Alzheimer's disease: lack of changes of the cortical content of quinolinic acid.

  1986cited by this paper
• Content of Quinolinic Acid and of Other Tryptophan Metabolites Increases in Brain Regions of Rats Used as Experimental Models of Hepatic Encephalopathy

  1986cited by this paper
• Quinolinic acid and other kynurenines in the central nervous system.

  1985cited by this paper
• Changes in Glutamate Receptors on Synaptic Membranes Associated with Hepatic Encephalopathy or Hyperammonemia in the Rabbit

  1984cited by this paper
• The excitotoxin quinolinic acid is present in the brain of several mammals and its cortical content increases during the aging process.

  1984cited by this paper
• THE USE OF ORGANOTYPIC TISSUE CULTURE FOR STUDY OF AMINO ACID NEUROTOXICITY AND ITS ANTAGONISM IN MAMMALIAN CNS

  1984cited by this paper
• The excitotoxin quinolinic acid is present and unevenly distributed in the rat brain.

  1984cited by this paper
• The Neurobiology of Hepatic Encephalopathy

  1984cited by this paper
• Alterations of Plasma and Brain Tryptophan in Hepatic Encephalopathy: A Study in Humans and in Experimental Animals

  1984cited by this paper
• Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain.

  1983cited by this paper
• The Release and Neosynthesis of Glutamic Acid Are Increased in Experimental Models of Hepatic Encephalopathy

  1983cited by this paper
• Differential vulnerability of central neurons of the rat to quinolinic acid.

  1983cited by this paper
• Brain Amino Acids Measured by Intracerebral Dialysis in Portacaval Shunted Rats

  1983cited by this paper
• Identification of quinolinic acid in rat and human brain tissue.

  1983cited by this paper
• HEPATIC ENCEPHALOPATHY AND THE γ-AMINOBUTYRIC-ACID NEUROTRANSMITTER SYSTEM

  1982cited by this paper
• Hepatic encephalopathy and the gamma-aminobutyric-acid neurotransmitter system.

  1982cited by this paper
• Experimental hepatic encephalopathy: changes in the binding of gamma-aminobutyric acid.

  1982cited by this paper
• Determination of Dopamine and Its Acidic Metabolites in Brain Tissue by HPLC with Electrochemical Detection in a Single Run After Minimal Sample Pretreatment

  1982cited by this paper
• An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid.

  1982cited by this paper
• Induction of coma in normal dogs by the infusion of aromatic amino acids and its prevention by the addition of branched-chain amino acids.

  1982cited by this paper
• Simultaneous quantification of dopamine, 5-hydroxytryptamine and four metabolically related compounds by means of reversed-phase high-performance liquid chromatography with electrochemical detection.

  1981cited by this paper
• Glial Fibrillary Acidic Protein in Hepatic Encephalopathy An Immunohistochemical Study

  1981cited by this paper
• Dietary precursors and brain neurotransmitter formation.

  1981cited by this paper
• Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS.

  1981cited by this paper
• A longitudinal study of tryptophan involvement in hepatic coma.

  1979cited by this paper
• Tryptophan in hepatic coma.

  1978cited by this paper
• SYNTHESIS AND METABOLISM OF l‐KYNURENINE IN RAT BRAIN

  1978cited by this paper
• Tryptophan and hepatic coma.

  1978cited by this paper
• Brain monoamines in human hepatic encephalopathy

  1978cited by this paper
• Alterations in Plasma and CSF Amino Acids, Amines and Metabolites in Hepatic Coma

  1978cited by this paper
• Changes in the tryptophan content of excised human cerebral cortex

  1977cited by this paper
• The effect of normalization of plasma amino acids on hepatic encephalopathy in man.

  1976cited by this paper
• REGIONAL BRAIN INDOLEAMINE METABOLISM FOLLOWING CHRONIC PORTACAVAL ANASTOMOSIS IN THE RAT

  1976cited by this paper
• REGIONAL BRAIN STUDY OF INDOLEAMINE METABOLISM IN THE RAT IN ACUTE HEPATIC FAILURE

  1976cited by this paper
• Relationships between tryptophan in serum and CSF, and 5-hydroxyindoleacetic acid in CSF of man: effect of cirrhosis of liver and probenecid administration.

  1975cited by this paper
• 5-HYDROXYTRYPTAMINE AND HEPATIC COMA

  1975cited by this paper
• Letter: 5-hydroxytryptamine and hepatic coma.

  1975cited by this paper
• Cerebrospinal fluid homovanillic acid, 5-hydroxyindoleacetic acid, lactic acid, and pH before and after probenecid in hepatic coma.

  1974cited by this paper
• Dopamine and Serotonin Metabolism in Hepatic Encephalopathy

  1974cited by this paper
• TRANSPORT OF l‐TRYPTOPHAN INTO SLICES OF RAT CEREBRAL CORTEX 1

  1972cited by this paper
• Tryptophan metabolism in liver disease.

  1971cited by this paper
• Tryptophan as cause of hepatic coma.

  1966cited by this paper
• THE ENZYMATIC CONVERSION OF QUINOLINATE TO NICOTINIC ACID MONONUCLEOTIDE IN MAMMALIAN LIVER.

  1964cited by this paper

• Quinolinic acid potentially links kidney injury to brain toxicity

  2025cites this paper
• Bile duct ligation elevates 5-HT levels in cerebral cortex of rats partly due to impairment of brain UGT1A6 expression and activity via ammonia accumulation

  2023cites this paper
• Increased serum levels of quinolinic acid indicate enhanced severity of hepatic dysfunction in patients with liver cirrhosis.

  2013cites this paper
• The Contribution of Ammonia to Methamphetamine Neurotoxicity

  2013cites this paper
• Peripheral Ammonia as a Mediator of Methamphetamine Neurotoxicity

  2012cites this paper
• Septic encephalopathy

  2012cites this paper
• Pathophysiology of Hepatic Encephalopathy: Studies in Animal Models

  2009cites this paper
• Pharmacology of the kynurenine pathway

  2007cites this paper
• Tryptophan, adenosine, neurodegeneration and neuroprotection

  2007cites this paper
• Chapitre 12 – Éthanol

  2007cites this paper
• Assessment of the kynurenine pathway in humans: I. Normal plasma values, ethnic differences and their clinical implications

  2007cites this paper
• Brain quinolinic acid in Alzheimer's dementia

  2005cites this paper
• The effect of age on the enzyme activities of tryptophan metabolism along the kynurenine pathway in rats.

  2005cites this paper
• Modulação do sistema glutamatérgico : estudo dos efeitos do ácido quinolínico e dos derivados da guanina

  2005cites this paper
• Microvascular disorder Reduced cerebral blood flow and increased cerebrovascular resistance are found in human cases of SAE

  2005cites this paper
• Carrier-mediated uptake of H2-receptor antagonists by the rat choroid plexus: involvement of rat organic anion transporter 3.

  2004cites this paper
• Sepsis-associated encephalopathy: Evolving concepts

  2003cites this paper
• Oral Tryptophan Challenge Studies in Cirrhotic Patients: No Evidence of Neuropsychiatric Changes

  2003cites this paper
• Progress in Clinical Neurosciences: Sepsis-Associated Encephalopathy: Evolving Concepts

  2003cites this paper
• Purification and inactivation of 3-hydroxyanthranilic acid 3,4-dioxygenase from beef liver.

  2003cites this paper
• Cerebrospinal fluid glutamine, tryptophan, and tryptophan metabolite concentrations in dogs with portosystemic shunts.

  2002cites this paper
• Erkrankungen, die zu einer organischen psychischen Störung führen können

  2002cites this paper
• Neurobiology of ammonia.

  2002cites this paper
• Effects or Influences on Organ Systems

  2001cites this paper
• Kynurenines in the CNS: from endogenous obscurity to therapeutic importance.

  2001cites this paper
• Marcadores diagnósticos y mecanismos neuroquímicos de la encefalopatía secundaria a la insuficiencia hepática

  2001cites this paper
• Kynurenine 3-mono-oxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis.

  2001cites this paper
• Anticonvulsant effects of the 3-hydroxyanthranilic acid dioxygenase inhibitor NCR-631

  2000cites this paper
• Effects of Mitochondria and O‐Methoxybenzoylalanine on 3‐Hydroxyanthranilic Acid Dioxygenase Activity and Quinolinic Acid Synthesis

  1999cites this paper
• 3-Hydroxyanthranilic acid accumulation following administration of the 3-hydroxyanthranilic acid 3,4-dioxygenase inhibitor NCR-631.

  1999cites this paper
• Amino acid metabolism in liver disease.

  1999cites this paper
• Brain tryptophan/serotonin perturbations in metabolic encephalopathy and the hazards involved in the use of psychoactive drugs.

  1999cites this paper
• Regulation of quinolinic acid synthesis by mitochondria and o-methoxybenzoylalanine.

  1999cites this paper
• Effects of kynurenine metabolites on the electrocorticographic activity in the rat

  1998cites this paper
• Roles of neuroactive amino acids in ammonia neurotoxicity

  1998cites this paper
• Role of tryptophan in the elevated serotonin-turnover in hepatic encephalopathy

  1998cites this paper
• Oxindole, a Sedative Tryptophan Metabolite, Accumulates in Blood and Brain of Rats with Acute Hepatic Failure

  1998cites this paper
• Brain tryptophan perturbation in hepatic encephalopathy: implications for effects by neuropsychoactive drugs in clinical practice.

  1997cites this paper
• Role of efflux transport across the blood-brain barrier and blood-cerebrospinal fluid barrier on the disposition of xenobiotics in the central nervous system☆

  1997cites this paper
• Concentrations of quinolinic acid in cerebrospinal fluid measured by gas chromatography and electron-impact ionisation mass spectrometry. Age-related changes in a paediatric reference population.

  1997cites this paper
• Biochemical characteristics of gamma-glutamyl transpeptidase in capillaries from entorhinohippocampal complex of quinolinate-lesioned rat brain.

  1997cites this paper
• Studies on the pharmacological properties of oxindole (2-hydroxyindole) and 5-hydroxyindole: are they involved in hepatic encephalopathy?

  1997cites this paper
• Neurochemical and metabolic consequences of elevated cerebrospinal fluid quinolinic acid concentrations in rat brain.

  1997cites this paper
• Is quinolinic acid involved in the pathogenesis of hepatic encephalopathy?

  1996cites this paper
• Brain Extracellular Quinolinic Acid in Chronic Experimental Hepatic Encephalopathy as Assessed by In Vivo Microdialysis: Acute Effects of L-Tryptophan

  1996cites this paper
• Review article: pathogenesis and treatment of chronic hepatic encephalopathy.

  1996cites this paper
• The effect of quinolinate on rat brain lipid peroxidation is dependent on iron.

  1996cites this paper
• Regulation of quinolinic acid in the normal rat brain by kynurenine pathway precursors.

  1996cites this paper
• NMDA Receptor antagonists prevent acute ammonia toxicity in mice

  1996cites this paper
• Cytokine contribution to the repair processes and homeostasis recovery following anoxic insult: a possible IFN-gamma-regulating role in IL-1beta neurotoxic action in physiological or damaged CNS.

  1996cites this paper
• Neuropsychiatric implications of brain tryptophan perturbations appearing in hepatic encephalopathy.

  1996cites this paper
• pathogenesis and treatment of chronic hepatic encephalopathy

  1996cites this paper
• Loss of [3H]MK801 binding sites in brain in congenital ornithine transcarbamylase deficiency

  1995cites this paper
• Brain Quinolinic Acid in Chronic Experimental Hepatic Encephalopathy: Effects of an Exogenous Ammonium Acetate Challenge

  1995cites this paper
• Neurotransmitter alterations in congenital hyperammonemia

  1995cites this paper
• Chapter 28 Trace amines in hepatic encephalopathy

  1995cites this paper
• Trace amines in hepatic encephalopathy.

  1995cites this paper
• Cytokines in the central nervous system: regulatory roles in neuronal function, cell death and repair.

  1995cites this paper
• Prenatal Exposure of Rats to Ammonia Impairs NMDA Receptor Function and Affords Delayed Protection Against Ammonia Toxicity and Glutamate Neurotoxicity

  1995cites this paper
• [The glutaminergic system (II): the physiopathological, clinical and therapeutic aspects].

  1995cites this paper
• The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy.

  1995cites this paper
• The Relationship Between Plasma and Brain Quinolinic Acid Levels and the Severity of Hepatic Encephalopathy in Animal Models of Fulminant Hepatic Failure

  1995cites this paper
• 3-Hydroxyanthranilic acid oxygenase-containing astrocytic processes surround glutamate-containing axon terminals in the rat striatum

  1995cites this paper
• Quinolinic acid in neurological disease: opportunities for novel drug discovery.

  1994cites this paper
• Current Theories on the Pathogenesis of Hepatic Encephalopathy

  1994cites this paper
• 4-Chloro-3-hydroxyanthranilate inhibits quinolinate production in the rat hippocampus in vivo.

  1994cites this paper
• 45CaCl2 autoradiography in brain from rabbits with encephalopathy from acute liver failure or acute hyperammonemia

  1994cites this paper
• Famotidine‐associated central nervous system reactions and plasma and cerebrospinal drug concentrations in neurosurgical patients with renal failure

  1994cites this paper
• Kynurenic acid distribution into brain and peripheral tissues of mice.

  1994cites this paper
• Pharmacokinetic/Pharmacodynamic Evaluation of the Risk of Adverse Reaction on Central Nervous System Induced by H2 receptor antagonists. Hepatic and/or Renal Disease as Risk Factors.

  1993cites this paper
• On the Production and Disposition of Quinolinic Acid in Rat Brain and Liver Slices

  1993cites this paper
• Neuropharmacology of quinolinic and kynurenic acids.

  1993cites this paper
• Intravenous administration of L-kynurenine to rhesus monkeys: effect on quinolinate and kynurenate levels in serum and cerebrospinal fluid.

  1993cites this paper
• Quinolinic acid in children with congenital hyperammonemia

  1993cites this paper
• Neuroexcitation, excitotoxicity and human neurological disease.

  1993cites this paper
• History and Basic Concepts

  1993cites this paper
• The role of tryptophan in hepatic encephalopathy

  1993cites this paper
• Effects of tryptophan metabolites on brain function: Electrocorticographical study

  1992cites this paper
• Cerebrospinal fluid (CSF) analyses in HIV-1 primary neurological disease

  1992cites this paper
• Recent developments in the pathophysiology and treatment of hepatic encephalopathy.

  1992cites this paper
• Quinolinate in Brain and Cerebrospinal Fluid in Rat Models of Congenital Hyperammonemia

  1992cites this paper
• Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.

  1992cites this paper
• Effect of ammonium ions on synaptic transmission in the mammalian central nervous system.

  1992cites this paper
• Blood–Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism

  1991cites this paper
• Excitotoxic mechanisms in Huntington's disease

  1991cites this paper
• Quinolinic acid and kynurenic acid in the mammalian brain.

  1991cites this paper
• 4-halo-3-hydroxyanthranilic acids: potent competitive inhibitors of 3-hydroxy-anthranilic acid oxygenase in vitro.

  1991cites this paper
• Is quinolinic acid an endogenous excitotoxin in alcohol withdrawal?

  1991cites this paper
• Implications of interferon-induced tryptophan catabolism in cancer, auto-immune diseases and AIDS.

  1991cites this paper
• Determination of 3-hydroxykynurenine in human brain and plasma by high-performance liquid chromatography with electrochemical detection. Increased concentrations in hepatic encephalopathy.

  1991cites this paper
• Modulation of Quinolinic and Kynurenic Acid Content in the Rat Brain: Effects of Endotoxins and Nicotinylalanine

  1991cites this paper
• Kynurenine metabolites of tryptophan

  1990cites this paper
• Quinolinate neurotoxicity and glutamatergic structures.

  1990cites this paper
• [Endogenous factors of neurodestruction (the pharmacologic aspects)].

  1990cites this paper
• Quantification of kynurenic acid in cerebrospinal fluid: effects of systemic and central L-kynurenine administration.

  1990cites this paper
• Increased Cerebrospinal Fluid Quinolinic Acid, Kynurenic Acid, and L‐Kynurenine in Acute Septicemia

  1990cites this paper
• Hepatic encephalopathy influences high-affinity uptake of transmitter glutamate and aspartate into the hippocampal formation

  1990cites this paper
• The Use of Cultured Astrocytes in the Study of Hepatic Encephalopathy

  1989cites this paper
• No changes in central quinolinic acid levels in Alzheimer's disease.

  1989cites this paper
• Neuroactive metabolises of L‐tryptophan, serotonin and quinolinic acid, in striatal extracellular fluid effect of tryptophan loading

  1989cites this paper